Related Experiment Video
Updated: Jan 14, 2026

Assessment of the Metabolic Effects of Isocaloric 2:1 Intermittent Fasting in Mice
Published on: November 27, 2019
Rationale and protocol for a randomized parallel intervention trial of two intermittent fasting approaches in
Felicia L Steger1, Joseph E Donnelly2, Robert N Montgomery3
1Division of Endocrinology, Diabetes, and Clinical Pharmacology and KU Diabetes Institute; Department of Internal Medicine, University of Kansas Medical Center, Kansas City, KS, USA; Department of Dietetics and Nutrition, University of Kansas Medical Center, Kansas City, KS, USA; Kansas Center for Metabolism and Obesity Research, Kansas City, KS, USA.
This study compares intermittent energy restriction (IER) and time-restricted eating (TRE) for type 2 diabetes (T2D) management. Results will guide personalized nutrition strategies for T2D patients with overweight or obesity.
Area of Science:
- Endocrinology and Metabolism
- Nutritional Science
- Diabetes Research
Background:
- Type 2 diabetes (T2D) involves insulin resistance and beta-cell dysfunction, often worsened by obesity.
- Intermittent fasting (IF) methods like intermittent energy restriction (IER) and time-restricted eating (TRE) show potential for improving glycemic control and diabetes remission.
- The comparative effectiveness and feasibility of IER versus TRE in T2D patients are not well-established.
Purpose of the Study:
- To compare the feasibility, acceptability, and metabolic outcomes of IER and TRE in adults with T2D.
- To evaluate changes in glycemic control, insulin sensitivity, and body composition.
- To identify predictors of response to different IF strategies.
Main Methods:
- A randomized parallel trial involving 56 adults with T2D and overweight/obesity.
- Intervention groups: IER (specific calorie restriction on 2-3 days/week) or TRE (8-hour daily eating window).
- Both groups received remote diabetes education and behavioral support for 6 months, followed by self-managed continuation.
Main Results:
- Primary outcomes assessed feasibility (recruitment, retention, adherence) and acceptability.
- Secondary outcomes included changes in HbA1c, insulin sensitivity, insulin response, body composition, and diabetes remission rates.
- Continuous glucose monitoring and metabolic phenotyping were used to identify response predictors.
Conclusions:
- This is the first parallel trial directly comparing IER and TRE in T2D patients with overweight/obesity.
- The study will yield crucial data on metabolic and behavioral responses to IER and TRE.
- Findings will inform personalized nutrition therapy strategies for managing T2D.
More Related Videos
06:13Author Spotlight: Exploring the Impact of Reduced Resistance Exercise Volume on Metabolic Health
Published on: December 1, 2023
12:59Improving Strength, Power, Muscle Aerobic Capacity, and Glucose Tolerance through Short-term Progressive Strength Training Among Elderly People
Published on: July 5, 2017
Related Concept Videos
Bioavailability Study Design: Healthy Subjects Versus Patients
Diabetes: Management and Pharmacotherapy
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Insulin: Dosing Regimen and Adverse Effects
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...